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Lyme Disease
Jared Hostetler BSN, RN
Otterbein University, Westerville, Ohio
Introduction
Lyme disease is the most common
vector borne illness found in the United
States. Each year 30,000 people are
diagnosed with the disease, with many
more cases going unreported (Centers
for Disease Control and Prevention,
2015). The vector responsible for
spreading the disease is the deer tick. The
infection itself is caused by the spirochete
Borrelia burgdorferi. This bacteria is
transmitted through the saliva from the
bite of a deer tick. Diagnosis can be
challenging due to the fact that multiple
systems of the body can be affected with
different severities. Early diagnosis and
treatment is critical in the prevention of
progressive and chronic illness.
Lyme disease is a relevant issue of
rural Northeast Ohio. The prevalence of
the disease is not as common as the high
risk areas in the New England states.
However, deer ticks can easily be found
in any woods close to home. This disease
requires more awareness and research
within the healthcare community. The
pathology of the disease is understood,
but details of exactly how Borrelia
burgdorferi affects certain areas of the
body such as the nervous system remains
unclear (Halperin, 2014). More
importantly physicians and advanced
practice nurses in this area need
educated on signs and symptoms of the
disease so a timely diagnosis can be
made. Treatment is simple and
complications are preventable with early
diagnosis. Borrelia burgdorferi has been
extensively researched, but more
information is needed to fully
understand how this bacteria has
mastered the ability to evade human
immunity (Kenedy, Lenhart, & Akins,
2012).

Disease Process/Signs and Symptoms
The beginning stage in the
development of Lyme disease is most
recognized as the localized rash called
erythema migrans. It is also commonly
called “bull’s eye rash” due to its
physical appearance. The rash forms
after about 3-30 days after the tick bite
and is around 5 cm in diameter but may
spread up to around 30 cm (Pearson,
2015). This early phase of the infection
is the easiest time to diagnose the
disease when erythema migrans is
present. It is the classic symptom of
Lyme disease but fades as the individual
progresses to the further stages of
infection. Erythema migrans is usually
not irritating or painful and can many
times go unnoticed without the presence
of any systemic involvement, presenting
as flu like symptoms (Pearson, 2015).
Early dissemination of Lyme disease
accompanies symptoms of fever,
headache, musculoskeletal pain, and
general malaise. Secondary lesions of
erythema migrans may also be present
(Pearson, 2015). Many other body
systems begin to be affected as Borrelia
burgdorferi migrates throughout the
tissues.

Joint and muscles are commonly
affected causing pain with or without
inflammation of the joint. Neurological
symptoms present with Bell's palsy like
paralysis of the cranial nerves and
radicular neuropathies leading to other
peripheral manifestations.
Cardiovascular symptoms are not as
common but can lead to varying degrees
of heart block (Bratton et al., 2008).
Late dissemination of Lyme disease
involves chronic relapsing and remitting
symptoms of the bodily system affected
by the bacteria. Peripheral, central and
autonomic nervous systems can be
chronically affected in some of the
population with Lyme disease (Pearson,
2015). This includes a vast and complex
presentation of symptoms making
diagnosis even more difficult once it has
reached the later stages. Pearson (2015)
describes these symptoms as
encephalopathy, headache, mood
changes, peripheral neuropathy, and
even blood pressure changes (p. 89).
Collagen rich tissues are usually the site
of chronic disease including the eyes,
nerve tissues and joints causing many
sensory and motor deficits (Pearson,
2015).

Left: Erythema Migrans
rash after a tick bite.
Copyright 2015 by CDC.

Right: Areas of the United
States at highest risk for
Lyme disease. Copyright 2013
by CDC.

Underlying pathophysiology
The underlying pathophysiology of Lyme disease begins in the white footed mouse
acting as the reservoir for B. burgdorferi and the deer tick acting as the vector to spread
the bacteria to humans. The tick usually feeds for one to two days, transmitting the bacteria
through its saliva (Bratton et al., 2008). The initial infection identified as erythema migrans
is a localized immune response that takes place in the skin. B. burgdorferi disseminates to
other organs of the body in about two weeks. The outer surface protein of the bacteria
quickly triggers chemokines that attract B cells which then produce antibodies specific to
the B. burgdorferi. (Halperin, 2014). The inflammatory symptoms are a humoral and
cellular immune response to the outer surface protein which is then believed to trigger an
auto immune response (Steere, Drouin, & Glickstein, 2015).
The exact microbiology of the disease is still controversial due to the fact that it is very
hard to find evidence of bacterial presence in samples thought to be infected with the
spirochete. It is hard to imagine that such a small presence of the pathogen is able to create
such a strong immune reaction (Halperin, 2015). Chronic joint inflammation along with
neurological deficits can persist even when no bacteria is detected after treatment with
antibiotics (Steere et al, 2011).
One thing that is certain is that B burgdorferi has become proficient at evading
immunity through antigenetic variations of the outer surface protein and having the ability
to bind to human tissues (Kenedy et al., 2012). This may describe how the human immune
system becomes sensitive to self tissues through molecular mimicry eventually attacking
its own cells. Once systemic Lyme disease has developed, antibiotics become less effective
and chronic remitting symptoms last throughout the lifetime.

Right: Deer tick
commonly found in North
America. Copyright 2013
by My Times

Significance of Pathophysiology
The severity of the disease is based entirely on how quickly Lyme disease is recognized
and treated along with where the bacteria have colonized in the body. Not everyone
presents with the same symptoms since the B. burgdorferi bacteria has the ability to
invade such a variety of tissues and organs throughout the body. The symptoms tend to
vary even more as the disease progresses. For example, one patient may present with
complaints of peripheral neuropathy and joint pain while another may only complain of
muscle pain. It would appear as if the two cases are completely unrelated when in fact
they are both infected with the same pathogen. The only symptom that remains consistent
between cases is the early sign of the erythema migrans rash (Pearson, 2015).
The difficulty to diagnose this disease has led to the estimate that as many as one
million people are infected each year. This is much higher than the CDC’s report of around
30,000 cases annually. The cause of the under diagnosing is the vague and subjective
symptoms that present late in the disease along with the strict diagnostic guidelines to
make it definitive for Lyme disease (Stricker & Johnson, 2014). Another source claims
similar predictions of the true number of new cases, ranking it seventh in infectious
diseases in the United States. The same study also reported the financial burden and
healthcare resources needed to manage the chronic condition. Research showed that
healthcare costs for those with Lyme disease is almost $3,000 more a year with 87% more
outpatient visits compared to the control group (Adrion, Aucott, & Weiner, 2014). This is a
clear indication of the debilitating effects of Lyme disease when it has progressed to the
later stages

Implications for Nursing Care
The most important aspect of care is early treatment of the disease,
but first the diagnosis must be made. Diagnosis can be made one of two
ways, usually in a two step combination of the tests. These tests are the
enzyme-linked immunosorbent assay, commonly called ELISA, and the
Western blot test. The presentation of erythema migrans rash along with
patient history of outdoors and exposure to ticks should indicate the
presence of infection. Treatment should begin even before the lab results
confirm diagnosis (Kowalski, Tata, Berth, Mathiason, & Agger, 2010). As
stated earlier, it is difficult to make a diagnosis in the later stages of
disease since the healthcare provider only has subjective symptoms that
mimic other diseases. This is why it is important to conduct a thorough
history including knowledge of geographical hotspots for prevalence of
Lyme disease.
The early stage of Lyme disease is easily treated and with a good
prognosis. This is when first symptoms of fever and erythema migrans
rash are present. The two common antibiotics used to fight the infection
is a ten to twenty day treatment of doxycycline or amoxicillin. Research
has shown that the exact duration even with treatment less than ten days
has no effect on outcome (Kowalski et al., 2010).
Late stages of infection are more often difficult to cure. There is no
standard treatment for disseminated Lyme disease. Both IV and oral
antibiotics are used with controversy that usually point to the ineffective
results. Symptoms can be managed with anti-inflammatories, and other
treatments based on which bodily system is involved. Unfortunately,
there is still much unknown about the actions of the B. burgdorferi in the
late stages, so there is no set standard of care in the chronic form
(Halperin, 2014).
Another important topic to discuss is prevention measures and to
educate the patient on signs and symptoms of the disease. This is
especially important in areas such as the New England States where the
disease is most prevalent. However, it is not limited to those states and
can be found anywhere the deer tick can survive. People who are
outdoor enthusiasts such as hikers and hunters are at greater risk for
Lyme disease and need to be reminded to check their skin for ticks.
Insect repellant and protective clothing can offer an effective barrier
against ticks getting to the skin. Finally, providing education on common
signs and symptoms of disease such as fever and erythema migrans is
important so these conditions are not overlooked (Harvard Medical
School, 2014).

Conclusion
Lyme disease is a mysterious illness that continues to outsmart
those in the medical profession due to its ability to evade human
immunity. There is much more research and clinical trials needed to
effectively combat or even manage the symptoms of disease once it
reaches the chronic form. Lyme disease often goes undetected in the early
stages and therefore gets under diagnosed. It can be difficult to diagnose
when the symptoms mimic other diseases and affect many different
organs of the body. That is why it is so important that healthcare
providers are up to date with their knowledge so a diagnosis can be made
with immediate treatment. If left untreated, the physical, financial, and
emotional toll can last a lifetime.
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